SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-11-055274
Filing Date
2011-05-31
Accepted
2011-05-31 13:01:45
Documents
13
Period of Report
2011-07-15
Effectiveness Date
2011-05-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A b85110dfdef14a.htm DEF 14A 402564
2 GRAPHIC b85110dfb8511000.gif GRAPHIC 953
3 GRAPHIC b85110dfb8511021.gif GRAPHIC 1214
4 GRAPHIC b85110dfb8511022.gif GRAPHIC 1657
5 GRAPHIC b85110dfb8511001.gif GRAPHIC 1386
6 GRAPHIC b85110dfb8511002.gif GRAPHIC 2103
7 GRAPHIC b85110dfb8511003.gif GRAPHIC 10885
8 GRAPHIC b85110dfb8511004.gif GRAPHIC 7966
9 GRAPHIC b85110dfb8511007.gif GRAPHIC 786
10 GRAPHIC b85110dfb8511006.gif GRAPHIC 814
11 GRAPHIC b85110dfb8511005.gif GRAPHIC 2106
12 GRAPHIC b85110dfb8511008.gif GRAPHIC 13088
13 GRAPHIC b85110dfb8511015.gif GRAPHIC 1386
  Complete submission text file 0000950123-11-055274.txt   466479
Mailing Address 60 PRESCOTT STREET WORCESTER MA 01605
Business Address 60 PRESCOTT STREET WORCESTER MA 01605 508-767-3861
RXI PHARMACEUTICALS CORP (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 11880519
SIC: 2834 Pharmaceutical Preparations